BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1425112)

  • 1. Response to "Topical phenytoin in diabetic foot ulcers".
    Kumar S; Boulton AJ
    Diabetes Care; 1992 Oct; 15(10):1433-4. PubMed ID: 1425112
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical phenytoin in diabetic foot ulcers.
    Muthukumarasamy MG; Sivakumar G; Manoharan G
    Diabetes Care; 1991 Oct; 14(10):909-11. PubMed ID: 1773690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of topical phenytoin as an adjunct to immobilization in the treatment of trophic leprosy ulcers.
    Menezes J; Rajendran A; Jacob AJ; Vaz M
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):340-2. PubMed ID: 8266239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophic skin ulceration in leprosy: evaluation of the efficacy of topical phenytoin sodium zinc oxide paste.
    Sehgal VN; Prasad PV; Kaviarasan PK; Rajan D
    Int J Dermatol; 2014 Jul; 53(7):873-8. PubMed ID: 24601869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and treatment of diabetic foot ulcer.
    Hollingshead TS
    Clin Podiatr Med Surg; 1991 Oct; 8(4):843-55. PubMed ID: 1933735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration.
    El-Nahas M; Gawish H; Tarshoby M; State O
    J Wound Care; 2009 Jan; 18(1):33-7. PubMed ID: 19131916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silicone injection management of diabetic foot ulcers: a possible model for prevention of pressure ulcers.
    Balkin SW; Kaplan L
    Decubitus; 1991 Nov; 4(4):38-40. PubMed ID: 1760123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol.
    Fernando ME; Crowther RG; Cunningham M; Lazzarini PA; Sangla KS; Golledge J
    BMC Endocr Disord; 2015 Oct; 15():59. PubMed ID: 26499881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area.
    Ince P; Game FL; Jeffcoate WJ
    Diabetes Care; 2007 Mar; 30(3):660-3. PubMed ID: 17327337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
    Reiber GE; Vileikyte L; Boyko EJ; del Aguila M; Smith DG; Lavery LA; Boulton AJ
    Diabetes Care; 1999 Jan; 22(1):157-62. PubMed ID: 10333919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total contact cast for neuropathic diabetic foot ulcers.
    Ali R; Qureshi A; Yaqoob MY; Shakil M
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):695-8. PubMed ID: 18983793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers: Response to Liu et al.
    Muller M; Trocme C; Morel F; Halimi S; Benhamou PY
    Diabetes Care; 2009 Nov; 32(11):e138. PubMed ID: 19875601
    [No Abstract]   [Full Text] [Related]  

  • 13. The diabetic foot: from art to science. The 18th Camillo Golgi lecture.
    Boulton AJ
    Diabetologia; 2004 Aug; 47(8):1343-53. PubMed ID: 15309286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diabetic foot].
    Lechleitner M; Francesconi M; Abrahamian H
    Acta Med Austriaca; 2004; 31(5):173-4. PubMed ID: 15747993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical phenytoin for wound healing.
    Bhatia A; Prakash S
    Dermatol Online J; 2004 Jul; 10(1):5. PubMed ID: 15347487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malum perforans diabeticorum: treatment with controlled circulatory blockade and regional intravenous administration of antibiotics].
    Acevedo A; Decinti E; Toledo L; PĂ©rez O
    Wien Med Wochenschr; 1993; 143(7-8):195-8. PubMed ID: 8379176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.
    Bowling FL; Salgami EV; Boulton AJ
    Diabetes Care; 2007 Feb; 30(2):370-1. PubMed ID: 17259512
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving outcomes in recurrent and other new foot ulcers after healed plantar forefoot diabetic ulcer.
    Scott Nickerson D
    Wound Repair Regen; 2018 Jan; 26(1):108-109. PubMed ID: 29363877
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo.
    Steed DL; Goslen JB; Holloway GA; Malone JM; Bunt TJ; Webster MW
    Diabetes Care; 1992 Nov; 15(11):1598-604. PubMed ID: 1468291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of foot self-care behavior on developing foot ulcers in diabetic patients with peripheral neuropathy: a prospective study.
    Chin YF; Liang J; Wang WS; Hsu BR; Huang TT
    Int J Nurs Stud; 2014 Dec; 51(12):1568-74. PubMed ID: 24866324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.